Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08VWL
|
||||
| Former ID |
DIB010490
|
||||
| Drug Name |
BRL-42715
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Terminated | [1] | ||
| Company |
SmithKline Beecham plc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H7N4NaO3S
|
||||
| Canonical SMILES |
N12C(=O)/C(=C/c3nnn(c3)C)/[C@H]1SC=C2C(=O)[O-].[Na+]
|
||||
| CAS Number |
CAS 102209-75-6
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001128) | ||||
| REF 2 | In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33(9):1580-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.